AstraZeneca (AZN), and Cardinal Health (CAH) on Friday, arguing that the trio of healthcare stocks, which recorded their best ...

Cardinal Health, Inc. (NYSE:CAH) is included among the 20 Best Performing Dividend Stocks in 2025. Cardinal Health, Inc.

The concentration of the health care distribution industry provides Cardinal Health and AmerisourceBergen with competitive advantages and high barriers to entry. This provides Cardinal Health and ...

News headlines Cardinal Health (CAH) is gaining attention for its solid financial metrics and dividend prospects as it navigates a growing MedTech market. Recent analyses suggest the stock may be ...

Pharmaceutical distributor Cardinal Health is eyeing an expanded footprint in the specialty medicine space through the planned acquisitions of GI Alliance (GIA) and Advanced Diabetes Supply Group (DSG ...

Cardinal Health is a leader in its industry and has had another stellar quarterly performance with revenues increasing 13%. A part of a growing industry, the company has both a strong financial ground ...

Cardinal Health is building its drug distribution portfolio with the acquisition of Kinray, Inc., a Whitestone, N.Y.-based privately held distributor of branded and generic medicines to more than ...

Use of Non-GAAP MeasuresThis earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). In addition to analyzing ...

Cardinal Health, Inc. corporate office in Dublin, Ohio. As Cardinal Health continues its digital transformation efforts, newly appointed Chief Information Officer Michelle Greene is focused on ...

With the onset of the Covid-19 pandemic, Cardinal Health made the decision they needed enhanced visibility into PPE shipments as demand for these products surged. Since then, FourKites has become a ...

The COVID-19 pandemic exposed critical flaws in hospital supply chains for vital equipment like ventilators and personal protective gear. Many health systems struggled with shortages and often ...

Four companies that agreed to pay a combined $26 billion to settle claims about their roles in the opioid crisis plan to deduct some of those costs from their taxes and recoup around $1 billion apiece ...